"MS drugs harm the vaccine" Israel today

An Israeli study reveals that 2 out of 3 MS drugs harm corona antibody production • Which drug does not affect the vaccine?

• Study: MS drugs impair corona vaccine effectiveness

  Photo: 

  Gideon Markovich

Do MS drugs impair corona vaccine effectiveness?

This is at least the conclusion of a study conducted at Sheba Hospital.

According to the study, MS patients are at risk of not developing corona vaccine antibodies, due to the medication they are taking regularly. 

This is further evidence that there are people being treated with drugs that suppress the immune system for whom the vaccine for corona is ineffective.

The study sought to test whether the regular treatment taken by MS patients, an autoimmune disease that affects the central nervous system, adversely affects the immune system's response to corona. The study looked at MS patients taking drugs of three different types. The results showed that those who were treated with a drug called "Maybenclad" actually developed antibodies at the same rate as patients without MS who were vaccinated against Corona - all 23 patients who were treated with Maybenclad (100%) and received the Pfizer vaccine developed an IgG antibody response against Corona virus. It was similar to that documented in MS patients who did not receive treatment affecting the immune system, and to the response described in a control group of healthy participants, regardless of their lymphocyte levels.

In the other MS field, the results were less encouraging: only one-fifth of patients treated with the drug "Ocruves" (44 patients in the study) developed antibodies to the vaccine (22%). Among 26 patients taking a drug called Gilnia, only one developed antibodies in response to the corona vaccine. .

The patients in the study were compared to 47 healthy patients and 32 MS patients who did not take any treatment.

Prof. Anat Ahiron, director of the Sheba Multiple Sclerosis Center, summed up the conclusions from the study: "Treatment with Maybenklad did not affect the immune response to the corona vaccine. Gilnia ".